| Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing P Sharma, JR Klemp, BF Kimler, JD Mahnken, LJ Geier, QJ Khan, M Elia, ... Breast cancer research and treatment 145, 707-714, 2014 | 208 | 2014 |
| BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation SR Stecklein, E Kumaraswamy, F Behbod, W Wang, V Chaguturu, ... Proceedings of the National Academy of Sciences 109 (34), 13650-13655, 2012 | 137 | 2012 |
| BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function E Kumaraswamy, KL Wendt, LA Augustine, SR Stecklein, EC Sibala, D Li, ... Oncogene 34 (33), 4333-4346, 2015 | 95 | 2015 |
| The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer P Sharma, SR Stecklein, BF Kimler, G Sethi, BK Petroff, TA Phillips, ... Journal of cancer therapeutics & research 3 (2), 1, 2014 | 73 | 2014 |
| Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer MS Ning, V Ahobila, A Jhingran, SR Stecklein, M Frumovitz, KM Schmeler, ... Gynecologic oncology 148 (1), 132-138, 2018 | 67 | 2018 |
| PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis A Paul, S Gunewardena, SR Stecklein, B Saha, N Parelkar, M Danley, ... Cell Death & Differentiation 21 (9), 1469-1481, 2014 | 52 | 2014 |
| Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC)(NeoPACT). P Sharma, SR Stecklein, R Yoder, JM Staley, K Schwensen, A O'Dea, ... Journal of Clinical Oncology 40 (16_suppl), 513-513, 2022 | 47 | 2022 |
| Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology SR Stecklein, RA Jensen Translational Research 160 (3), 178-197, 2012 | 44 | 2012 |
| Patterns of recurrence and survival in neuroendocrine cervical cancer SR Stecklein, A Jhingran, J Burzawa, P Ramalingam, AH Klopp, PJ Eifel, ... Gynecologic oncology 143 (3), 552-557, 2016 | 43 | 2016 |
| Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer P Sharma, VG Abramson, A O'Dea, L Nye, I Mayer, HB Pathak, ... Clinical Cancer Research 27 (14), 3896-3904, 2021 | 37 | 2021 |
| Improved locoregional control in a contemporary cohort of nonmetastatic inflammatory breast cancer patients undergoing surgery KJ Rosso, AB Tadros, A Weiss, CL Warneke, S DeSnyder, H Kuerer, ... Annals of surgical oncology 24, 2981-2988, 2017 | 37 | 2017 |
| Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy SR Stecklein, M Frumovitz, AH Klopp, JR Gunther, PJ Eifel Gynecologic oncology 148 (3), 474-479, 2018 | 33 | 2018 |
| Principles and practice of fertility preservation J Donnez, SS Kim Cambridge university press, 2011 | 33 | 2011 |
| Genetic and epigenetic signatures of breast cancer subtypes SR Stecklein, RA Jensen, A Pal Front Biosci (Elite Ed) 4, 934-949, 2012 | 27 | 2012 |
| Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer R Yoder, BF Kimler, JM Staley, K Schwensen, YY Wang, K Finke, A O’Dea, ... NPJ Breast Cancer 8 (1), 80, 2022 | 24 | 2022 |
| Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion ES Villodre, X Hu, R Larson, P Finetti, K Gomez, W Balema, SR Stecklein, ... Molecular oncology 15 (10), 2752-2765, 2021 | 24 | 2021 |
| Long-term impact of regional nodal irradiation in patients with node-positive breast cancer treated with neoadjuvant systemic therapy SR Stecklein, M Park, DD Liu, JJV Goffin, AS Caudle, EA Mittendorf, ... International Journal of Radiation Oncology* Biology* Physics 102 (3), 568-577, 2018 | 23 | 2018 |
| Emerging functions of microRNA-146a/b in development and breast cancer: microRNA-146a/b in development and breast cancer HS Elsarraj, SR Stecklein, K Valdez, F Behbod Journal of mammary gland biology and neoplasia 17, 79-87, 2012 | 19 | 2012 |
| Prospective comparison of toxicity and cosmetic outcome after accelerated partial breast irradiation with conformal external beam radiotherapy or single-entry multilumen … SR Stecklein, SF Shaitelman, GV Babiera, I Bedrosian, DM Black, ... Practical radiation oncology 9 (1), e4-e13, 2019 | 16 | 2019 |
| Efficacy of neoadjuvant carboplatin/docetaxel chemotherapy in sporadic and BRCA-associated triple-negative breast cancer (TNBC). P Sharma, SR Stecklein, BF Kimler, QJ Khan, CS Connor, M McGinness, ... Journal of Clinical Oncology 32 (15_suppl), 1022-1022, 2014 | 15 | 2014 |
Bruce KimlerПодтвержден адрес электронной почты в домене kumc.edu
